Depletion of YAP/TAZ in mice with renal tubular-specific Lats1/2 ablation, conversely, attenuated kidney cancer development, revealing the oncogenic role of YAP/TAZ activation in RCC progression [28]. This evidence concerns the gene LATS1 and kidney cancer.